HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prospective longitudinal study of corneal collagen cross-linking in progressive keratoconus.

AbstractBACKGROUND:
Collagen cross-linking has been reported to be effective in treating progressive keratoconus, and this study aims to evaluate the long-term efficacy of this procedure.
DESIGN:
Prospective longitudinal interventional study of patients with progressive keratoconus who underwent cross-linking in a tertiary referral hospital.
PARTICIPANTS:
Thirty-five patients (51 eyes) who underwent cross-linking with a mean follow-up of 14.38 ± 9.36 months (range 6-48) were compared with a control group of 25 fellow eyes that did not undergo the procedure.
METHODS:
Cross-linking was performed using 0.1% riboflavin (in 20% dextran T500) and ultraviolet A irradiation (370 nm, 3 mW/cm(2) , 30 min).
MAIN OUTCOME MEASURES:
Maximum keratometry in dioptres, logMAR best spectacle-corrected visual acuity, cylindrical power, manifest refraction spherical equivalent and central corneal thickness.
RESULTS:
Analysis of the treated group demonstrated a significant flattening of maximum keratometry by 0.96 ± 2.33 dioptres (P = 0.005) and a significant improvement in visual acuity by 0.05 ± 0.13 logMAR (P = 0.04). In the control group, maximum keratometry increased significantly by 0.43 ± 0.85 dioptres (P = 0.05), and visual acuity decreased by mean 0.05 ± 0.14 (P = 0.2). No statistical differences were noted regarding cylindrical power, spherical equivalent or corneal thickness in both groups.
CONCLUSIONS:
Results indicate that corneal collagen cross-linking using riboflavin and ultraviolet A is effective as a therapeutic option in cases of progressive keratoconus by reducing the corneal curvature and by improving the visual acuity in these patients.
AuthorsDeepa Viswanathan, John Males
JournalClinical & experimental ophthalmology (Clin Exp Ophthalmol) Vol. 41 Issue 6 Pg. 531-6 (Aug 2013) ISSN: 1442-9071 [Electronic] Australia
PMID23145528 (Publication Type: Journal Article)
Copyright© 2012 The Authors. Clinical and Experimental Ophthalmology © 2012 Royal Australian and New Zealand College of Ophthalmologists.
Chemical References
  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Collagen
  • Riboflavin
Topics
  • Adolescent
  • Adult
  • Collagen (metabolism)
  • Corneal Pachymetry
  • Corneal Stroma (metabolism)
  • Cross-Linking Reagents (therapeutic use)
  • Disease Progression
  • Female
  • Humans
  • Keratoconus (diagnosis, drug therapy, metabolism)
  • Longitudinal Studies
  • Male
  • Photosensitizing Agents (therapeutic use)
  • Prospective Studies
  • Refraction, Ocular (physiology)
  • Riboflavin (therapeutic use)
  • Ultraviolet Rays
  • Visual Acuity (physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: